This finding motivated us to investigate structural modifications of 5 with the intention of improving the affinity against MMP-7 while maintaining the appealing selectivity profile over MMP family members being anti-targets in cancer therapy such as MMP (-3, -8, -9, -12 and -14) [31]. Here, MMP7 is linked to cancer.